-
1
Efficacy and safety of SHEN26, a novel oral small molecular RdRp inhibitor for COVID-19 treatment: a multicenter, randomized, double-blinded, placebo-controlled, phase II clinical...
Published 2025-01-01Subjects: “…Oral small molecular antiviral drug…”
Get full text
Article -
2
Overview of Recent Advances in Canine Parvovirus Research: Current Status and Future Perspectives
Published 2024-12-01Subjects: Get full text
Article -
3
-
4
SARS-CoV-2 drug resistance and therapeutic approaches
Published 2025-01-01Subjects: “…Antiviral drugs…”
Get full text
Article